» Articles » PMID: 17597113

Nuclear Androgen Receptors Recur in the Epithelial and Stromal Compartments of Malignant and Non-malignant Human Prostate Tissue Several Months After Castration Therapy

Overview
Journal Prostate
Date 2007 Jun 29
PMID 17597113
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As changed paracrine support from androgen receptor (AR)-positive cells in the prostate stroma contribute to castration-induced glandular involution, we examined if the subsequent relapse to androgen-independent epithelial cell growth could be related to reactivation of AR signaling in the stroma.

Materials And Methods: Human prostate tissue taken before, within 14 days, and at suspected local tumor relapse after surgical castration therapy was immunostained for AR.

Results: Castration initially decreased nuclear AR staining in epithelial and stroma cells, in both tumor and non-malignant tissue, but after some months, it reappeared.

Conclusions: Local tumor relapse was associated with reappearance of nuclear AR not only in tumor epithelial cells but also in the tumor stroma. Reappearance of nuclear AR in non-malignant prostate cells may be a physiological response to long-term systemic androgen ablation that could influence tumor growth.

Citing Articles

Clinical relevance of androgen receptor alterations in prostate cancer.

Jernberg E, Bergh A, Wikstrom P Endocr Connect. 2017; 6(8):R146-R161.

PMID: 29030409 PMC: 5640574. DOI: 10.1530/EC-17-0118.


Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.

Vander Griend D, Litvinov I, Isaacs J Int J Biol Sci. 2014; 10(6):627-42.

PMID: 24948876 PMC: 4062956. DOI: 10.7150/ijbs.8756.


Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.

Wu J, Huang W, Zhou H, Xu L, Zhao J, Zhu J Asian J Androl. 2014; 16(5):710-4.

PMID: 24875819 PMC: 4215666. DOI: 10.4103/1008-682X.129131.


Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis.

Matuszak E, Kyprianou N Expert Rev Endocrinol Metab. 2013; 6(3):469-482.

PMID: 23667383 PMC: 3648215. DOI: 10.1586/eem.11.32.


Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J Am J Pathol. 2010; 177(2):1031-41.

PMID: 20616342 PMC: 2913352. DOI: 10.2353/ajpath.2010.100070.